Semme Moolenaar

Semme Moolenaar has a background in molecular biology/biotechnology and is specialized in deal- making, licensing, entrepreneurial experience, new business development, technology scouting, intellectual property strategy and commercialization.

He works for the Business Generator as technology transfer officer and as business coach for the Venturelab and he very recently became the CEO of SMIO Pharma, a start-up focusing on synthesis of small molecules for immuno-oncology in collaboration with the Domling – Drug Design Group from the University of Groningen.